Amidst the festival of Diwali, the government has announced a big decision for the common people. Medicines for breast cancer and lung cancer are going to become cheaper. Just before Diwali, such news has given a ray of hope to the middle class that they will be able to get better treatment. Along with this, the price of three medicines used in the treatment of cancer is also going to reduce.
The price of these medicines reduced
The government has directed manufacturers to reduce the prices of trastuzumab, osimertinib and durvalumab after exempting them from customs duty and reducing GST. The objective of this measure is to ensure affordable anti-cancer medicines to consumers. Companies must update and report new prices to authorities and dealers. For your information, let us tell you that Trastuzumab is used in the treatment of breast cancer, while Osimertineb is used in lung cancer and Durvalumab is used in both types of cancer.
It was said in this year’s budget itself that the custom duty will be reduced.
The government behind reducing cancer medicines said that our aim is to provide these essential medicines to the common people at low prices. This is the reason why NPPA has reduced the prices of medicines as much as possible. The GST rate on these medicines has also been reduced. For your information, let us tell you that when the budget was presented in the Parliament this year. Only then was there talk of reducing custom duty on essential medicines.
New prices implemented from October 10
The government had recently announced that the GST rate on medicines has been reduced from 12 percent to 5 percent. This is the reason why its MR P was reduced from October 10, 2024. Because its new price will be considered effective from the same day.
Disclaimer: Some information given in the news is based on media reports. Before implementing any suggestion, you must consult the concerned expert.
Check out below Health Tools-
Calculate Your Body Mass Index (BMI)
